New Melanoma Drugs Raise Hopes, But More Choices Needed
After years of failure in the treatment of advanced melanoma, two new drugs have emerged that help patients with one of the most deadly and difficult-to-treat cancers.
The experimental drug PLX4032 targets a specific genetic mutation found in the tumors of about half of all patients. Ipilimumab, an antibody that stimulates an immune system attack on melanoma, recently was approved by the U.S. Food and Drug Administration for treatment...
Gene Variation Links Lower Bladder Cancer Risk, Long Chromosome Tips
Like the plastic tips on shoelaces, telomeres sit at the end of chromosomes, protecting them from unraveling telomeres are protective, preventing...